Monitor for customer evaluations and pilot programs in food processing; the next catalyst would be a named customer contract or revenue contribution from the food safety vertical. Without financial disclosure, this remains a narrative-driven event.
Price Chart
Executive Summary
TOMI announced independent lab results showing SteraMist iHP sharply reduces Listeria monocytogenes in biofilm (flat surfaces: >7 log reduction; equipment parts: >3 log) and lactic acid bacteria (>5 log). The company has partnered with food industry veteran Dr. Josh Hasty to bring this data to food processors, targeting the $9.3B global food sanitation market. This is a commercial validation milestone for TOMI's food safety growth initiative, but no revenue or customer contracts were announced.
Key Facts
- SteraMist iHP achieved >7 log reduction of Listeria monocytogenes biofilm on flat surfaces (below detection limit).
- Lactic acid bacteria reduced by >5 log; Listeria on hard-to-reach equipment parts reduced by >3 log.
- TOMI partnered with Dr. Josh Hasty (former Tyson Foods and Cargill McDonald's food safety executive) to commercialize the data.
- Global food sanitation market estimated at $9.3B in 2025, projected to reach $17.4B by 2035 (6.5% CAGR).
- No revenue, customer contracts, or financial guidance were disclosed.
Financial Impact
No financial figures disclosed; market opportunity cited at $9.3B (2025) growing to $17.4B (2035), but TOMI's addressable share and current revenue contribution from food safety are not stated.
Risk Factors
- No customer contracts or revenue guidance provided; lab results may not convert to commercial sales.
- Food safety market is competitive with established disinfection alternatives; adoption cycle may be slow.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3381646 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $1.44 | awaiting T+20 | — | $1.49 (+3.47%) |
Oct 15, 2026 12d ago | Press Release | $1.50 | awaiting T+20 | — | $1.49 (−0.67%) |
Oct 1, 2026 26d ago | Press Release | $1.36 | awaiting T+20 | — | $1.49 (+9.56%) |
Sep 21, 2026 5w ago | 8-K | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.49 (+2.05%) |
Sep 21, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.49 (+2.05%) |
Sep 18, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +0.48% | $1.49 (+2.05%) |
Sep 2, 2026 7w ago | 8-K | $1.66 $1.36 | ▼ −18.07% | ▼ −17.92% | $1.49 (−10.24%) |
Aug 14, 2026 10w ago | 8-K | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.49 (−14.86%) |
Aug 14, 2026 10w ago | Press Release | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.49 (−14.86%) |
Jul 29, 2026 12w ago | 8-K | $1.52 $1.73 | ▲ +13.82% | ▲ +8.80% | $1.49 (−1.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers